Tafasitamab
CAS: 1422527-84-1
Ref. TM-T77135
| 1mg | 398.00 € | ||
| 5mg | 1,280.00 € | ||
| 10mg | 1,729.00 € | ||
| 25mg | 2,533.00 € | ||
| 50mg | 3,438.00 € | ||
| 100mg | 4,547.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
Product Information
Name:
Tafasitamab
Synonyms:
- XmAb5574
- Tafasitamab-cxix
- MOR00208
Description:
Tafasitamab (XmAb5574) is an FC-modified humanized monoclonal antibody targeting the human B-cell surface antigen CD19 for the study of diffuse large B-cell
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
147.41 kDa
Purity:
SDS-PAGE:95.2%;SEC-HPLC:99.3%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T77135 Tafasitamab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
